Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF Stem Cell Mobilization in Diamond-Blackfan Anemia
NCT00011505Phase 2Completed
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Feb 2001
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of filgrastim in Diamond-Blackfan anemia (DBA), sponsored by National Heart, Lung, and Blood Institute. Primary endpoint: CD34+ cell mobilization response to administration of standard doses of G-CSF at Day 5. Started Feb 2001; status: completed.
02
Drugs
filgrastim
03
Conditions
Diamond-Blackfan anemia (DBA)
Beyond the preview
Go deeper on NCT00011505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00011505.